ePRO Resources

31. Why eSource: The Advantages of Abandoning Paper Records 2/16/2023

    Eliminate transcription errors and fully leverage supporting eClinical technology to provide a reliable consistent exchange of information.

32. The New Standard In Participant-Centric Trials 8/21/2025

    Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.

33. Addressing The Specific Complexities Of Oncology eCOA Clinical Trials 4/18/2022

    What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.

34. Create Personalized Treatments With VR And RWD 5/13/2023

    Dive into the ways this cutting-edge technology is revolutionizing how healthcare providers create personalized treatment plans for patients suffering from chronic low back pain (CLBP).

35. Nevro Eliminates Majority Of Source Data Verification With ePRO And EDC 2/23/2023

    Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.

36. eCOA Predictions For 2022 5/2/2022

    Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.

37. Guide: How Connected Devices Improve Clinical Trial Data 5/29/2024

    Gain an overview of how and why connected devices provide sponsors and CROs with better clinical trial data, and offer patients much better trial experiences!

38. End-To-End Clinical Data Flow 6/24/2024

    Explore the interconnected data flow across Veeva Vault EDC, Veeva CDB, Veeva RTSM, and Veeva ePRO to visualize how these products work together seamlessly.

39. The Transformative Impact Of EDC Systems In 2025 5/6/2025

    The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.

40. Increase Participant Diversity With eClinical Tools 4/14/2023

    The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.